Schloss Wachenheim AG (LON:0G6J)
15.40
-0.30 (-1.91%)
At close: Oct 30, 2025
Schloss Wachenheim AG Revenue
In the fiscal year ending June 30, 2025, Schloss Wachenheim AG had annual revenue of 447.37M EUR with 1.33% growth. Schloss Wachenheim AG had revenue of 104.53M in the quarter ending June 30, 2025, with 0.90% growth.
Revenue
447.37M EUR
Revenue Growth
+1.33%
P/S Ratio
0.29
Revenue / Employee
287.33K EUR
Employees
1,557
Market Cap
110.94M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 447.37M | 5.86M | 1.33% |
| Jun 30, 2024 | 441.51M | 15.75M | 3.70% |
| Jun 30, 2023 | 425.75M | 41.78M | 10.88% |
| Jun 30, 2022 | 383.98M | 29.39M | 8.29% |
| Jun 30, 2021 | 354.58M | 16.37M | 4.84% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 140.08B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |